PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
40.22%
Revenue growth at 75-90% of AR's 49.18%. Bill Ackman would push for innovation or market expansion to catch up.
145.91%
Gross profit growth under 50% of AR's 466.69%. Michael Burry would be concerned about a severe competitive disadvantage.
94.03%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
94.03%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
16.06%
Net income growth under 50% of AR's 73.29%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.00%
EPS growth under 50% of AR's 73.37%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
16.00%
Diluted EPS growth under 50% of AR's 73.37%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.03%
Share reduction while AR is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.03%
Dividend growth of 0.03% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
80.98%
OCF growth above 1.5x AR's 6.49%. David Dodd would confirm a clear edge in underlying cash generation.
318.67%
Positive FCF growth while AR is negative. John Neff would see a strong competitive edge in net cash generation.
-26.89%
Negative 10Y revenue/share CAGR while AR stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-81.46%
Negative 5Y CAGR while AR stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-73.05%
Negative 3Y CAGR while AR stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
232.03%
OCF/share CAGR of 232.03% while AR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-47.72%
Negative 5Y OCF/share CAGR while AR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-56.79%
Negative 3Y OCF/share CAGR while AR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-1358.85%
Negative 10Y net income/share CAGR while AR is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-234.80%
Negative 5Y net income/share CAGR while AR is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-5178.11%
Negative 3Y CAGR while AR is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-14.95%
Negative equity/share CAGR over 10 years while AR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-71.85%
Negative 5Y equity/share growth while AR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-77.43%
Negative 3Y equity/share growth while AR is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
352.84%
Dividend/share CAGR of 352.84% while AR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-0.69%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-49.99%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-6.11%
Firm’s AR is declining while AR shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-63.93%
Inventory is declining while AR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-5.80%
Negative asset growth while AR invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.25%
We have a declining book value while AR shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.35%
Debt growth of 0.35% while AR is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
7.37%
SG&A growth well above AR's 13.99%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.